SCHEMBL3092196

SCHEMBL3092196

CCc1ccc(Cc2c(Cl)oc3ccc[c]c23)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3088499 0.84 THRA (0.31)
SCHEMBL3091845 0.71 KDM4E (0.30)
SCHEMBL3084411 0.71 LMNA (0.31)
SCHEMBL3078539 0.68 HTT (0.38)
SCHEMBL3087658 0.66 CYP1A2 (0.35)
SCHEMBL3082717 0.62 LMNA (0.34)
SCHEMBL3098415 0.62 POLB (0.33)
SCHEMBL27490282 0.62 TP53 (0.44)
SCHEMBL27561165 0.62 TRPA1 (0.38)
SCHEMBL3483331 0.62 CA2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207134-B2 Fused ring spiroketal derivative and use thereof as anti-diabetic drug CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2012-06-26 US disclosed
US-20100234609-A1 FUSED RING SPIROKETAL DERIVATIVE AND USE THEREOF AS ANTI-DIABETIC DRUG CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-09-16 US disclosed
EP-2048152-A1 FUSED RING SPIROKETAL DERIVATIVE AND USE THEREOF AS DRUG FOR TREATING DIABETES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-04-15 EP disclosed